Related by context. All words. (Click for frequent words.) 72 gliomas 66 glioblastoma 66 brain tumors 63 meningioma 62 medulloblastoma 62 frequently benign tumor 62 acoustic neuroma 60 uveal melanoma 60 lymphomas 60 adenocarcinoma 59 melanoma 59 tumors 58 acoustic neuromas 57 follicular lymphoma 57 meningiomas 57 malignancies 57 ependymoma 57 hepatocellular carcinoma 57 astrocytomas 56 Glioblastoma 56 carcinoma 56 medulloblastomas 56 malignant gliomas 56 Glioblastoma multiforme GBM 56 cancers 56 astrocytoma 55 parotid gland tumors 55 lymphoma 55 glioblastoma multiforme GBM 55 Glioblastomas 55 medullary thyroid cancer 55 grade gliomas 55 osteosarcoma 55 hepatocellular carcinoma HCC 55 prostate cancers 55 esophageal adenocarcinoma 55 salivary gland tumors 54 bladder cancers 54 adenoma 54 HER2 positive breast cancer 54 malignancy 54 HNSCC 54 basal cell carcinomas 54 Glioblastoma multiforme 54 seminoma 54 Wilms tumor 54 chronic lymphocytic leukemia CLL 54 CLL 54 neuroblastoma 54 Non Hodgkin lymphoma 54 glioblastoma multiforme 54 pancreatic adenocarcinoma 54 breast tumors 54 malignant melanoma 54 glioblastomas 54 neuroblastomas 54 squamous cell carcinoma 54 grade glioma 54 colorectal adenomas 53 invasive ductal 53 cutaneous melanoma 53 acute leukemias 53 basal cell carcinoma BCC 53 ovarian cancers 53 glioma rarer 53 breast carcinoma 53 Interphone study 53 basal cell carcinoma 53 leukaemias 53 renal cell carcinoma 53 metastatic cancer 53 gastric cancer 53 carcinomas 53 rectal cancers 53 HER2 positive cancers 53 sarcoma 53 ApoE4 53 glioma tumors 53 colorectal tumors 53 Glioma 53 malignant tumors 53 leukemia ALL 52 anaplastic 52 subependymal giant cell 52 neuroendocrine tumors 52 brain metastases 52 CaP 52 gastric cancers 52 sporadic ALS 52 adjuvant therapy 52 papillary thyroid cancer 52 INTERPHONE 52 sarcomas 52 ductal cancer 52 oropharyngeal cancer 52 esophageal squamous cell carcinoma 52 pheochromocytoma 52 Burkitt lymphoma 52 non Hodgkin lymphoma 52 paraganglioma 52 squamous cell carcinoma SCC 52 metastatic renal cell carcinoma 52 lung adenocarcinoma 52 KRAS wild 52 tumor recurrence 52 squamous cell carcinomas 52 tumor 52 lobular carcinoma 52 nasopharyngeal carcinoma 52 Cholangiocarcinoma 52 Interphone 52 gastrointestinal stromal tumor 52 ovarian tumors 52 differentiated thyroid 52 metastatic melanoma 52 testicular cancers 52 osteosarcomas 52 endometrial cancers 51 PCa 51 renal carcinoma 51 prostate cancer CaP 51 EGFR mutations 51 neoplasm 51 metastatic disease 51 Acute lymphoblastic leukemia 51 prostate adenocarcinoma 51 locoregional recurrence 51 metastases 51 synovial sarcoma 51 postmenopausal breast cancer 51 GISTs 51 neoplasms 51 malignant brain 51 childhood leukemia 51 prostate tumors 51 squamous cell cancer 51 Follicular lymphoma 51 non Hodgkin lymphomas 51 endometrial cancer 51 DLBCL 51 cranial radiation 51 thyroid tumors 51 BRCA mutations 51 invasive breast cancer 51 cell lymphomas 51 lung metastasis 51 acute myeloid leukemia 51 squamous cell cancers 51 indolent lymphoma 51 serous ovarian cancer 51 carcinoid 51 pancreatic cancers 51 Barrett esophagus 51 glioma malignant type 51 sarcomatoid 51 PCNSL 51 mammary tumors 51 ovarian cancer 51 nonmelanoma skin cancers 51 lobular cancer 51 carcinoid tumors 51 NF1 51 cell lymphoma 51 acute myelogenous leukemia AML 51 cervical carcinoma 50 ADPKD 50 neoplasia 50 biochemical recurrence 50 recurrent glioblastoma multiforme GBM 50 pheochromocytomas 50 lymphoblastic leukemia 50 small lymphocytic lymphoma 50 BRCA2 mutations 50 oligodendrogliomas 50 Stomach cancer 50 vandetanib 50 MALT lymphoma 50 solid tumors 50 colorectal carcinoma 50 histological subtype 50 indolent NHL 50 tarenflurbil 50 lymph node metastases 50 breast cancer metastasis 50 mCRC 50 breast cancers 50 bone metastasis 50 BRCA mutation carriers 50 glioblastoma tumors 50 Waldenstrom macroglobulinemia 50 operable breast cancer 50 ependymomas 50 advanced adenoma 50 distant metastases 50 CLL cells 50 colorectal cancers 50 gastrointestinal cancers 50 CMV infection 50 soft tissue sarcomas 50 advanced adenomas 50 preoperative chemotherapy 50 melanomas 50 lung cancers 50 WT1 50 nonmelanoma skin cancer 50 BRCA1 mutations 50 distant metastasis 50 axillary lymph nodes 50 colorectal cancer 50 gastric carcinoma 50 colorectal liver metastases 50 renal cell carcinomas 50 chemoradiation 50 cell acute lymphoblastic 50 nonsmall cell lung cancer 50 oesophageal cancer 50 grade cervical intraepithelial 50 pancreatic ductal adenocarcinoma 50 poorer prognosis 50 lung tumors 50 metastatic tumors 50 tumor shrinkage 50 papillary 50 telomere lengths 50 urothelial cancer 50 tumor histology 50 lymphoproliferative disorders 49 MYCN amplification 49 recurrent glioblastoma 49 colorectal cancer CRC 49 tumor progression 49 Glioblastoma Multiforme GBM 49 B CLL 49 squamous cell 49 uterine cancers 49 follicular lymphoma FL 49 endometrioid 49 BRAF mutations 49 skin cancers 49 chromosomal aberrations 49 recurrent glioblastoma multiforme 49 metastasis 49 neoadjuvant therapy 49 brain glucose metabolism 49 transitional cell carcinoma 49 developing meningioma 49 Gliomas 49 esophageal cancers 49 estrogen receptor negative 49 precancerous lesions 49 thyroid cancers 49 GBM tumors 49 prostate tumor 49 metastatic colorectal cancer 49 thromboembolic events 49 alveolar rhabdomyosarcoma 49 malignant glioma 49 relapsing remitting multiple sclerosis 49 lymph node involvement 49 localized prostate cancer 49 prostate cancer PCa 49 malignant lymphoma 49 NSCLC 49 brain tumor glioblastoma multiforme 49 Chronic lymphocytic leukemia 49 cancerous tumors 49 choriocarcinoma 49 eribulin 49 oropharyngeal squamous cell carcinoma 49 multiple myeloma MM 49 acute lymphoblastic 49 ALCL 49 myeloid leukemia 49 gastric adenocarcinoma 49 myeloproliferative disorders 49 cisplatin resistant 49 gastrointestinal GI cancers 49 malignant neoplasm 49 leukemia AML 49 squamous 49 rhabdomyosarcoma 49 liver metastases 49 leiomyosarcoma 49 BRCA2 mutation carriers 49 HER2 positive 49 heavily pretreated 49 Hepatocellular Carcinoma HCC 49 adenocarcinomas 49 BRCA1 mutation 49 intravenous bisphosphonates 49 essential thrombocythemia 49 pre cancerous lesions 49 embryonal rhabdomyosarcoma 49 leukemias 49 prostate pancreatic 49 non metastatic osteosarcoma 49 renal tumors 49 lymphocytic leukemia 49 bowel cancers 49 atypical hyperplasia 49 estrogen receptor positive 49 BRCA carriers 48 relapsing remitting 48 GIST 48 BRAF gene 48 glioblastoma GBM 48 Squamous 48 micrometastases 48 lymphocytic 48 mammary cancers 48 urothelial carcinoma 48 cell carcinomas 48 daunorubicin 48 radiosensitivity 48 pre menopausal 48 metastatic prostate cancer 48 hereditary breast cancer 48 HPV# 48 cardiac dysfunction 48 dasatinib 48 cancer 48 breast cancer recurrence 48 Glioblastoma Multiforme 48 Hashimoto thyroiditis 48 familial pancreatic cancer 48 BRCA2 mutation 48 histologic subtype 48 FGFR2 48 diabetes mellitus DM 48 ovarian carcinoma 48 prostate cancer 48 coronary calcification 48 GBMs 48 erlotinib Tarceva 48 HER2 overexpression 48 adenomas 48 squamous cell lung cancer 48 locoregional 48 NF kB pathway 48 Anaplastic 48 Malignant melanoma 48 progressive multifocal leukoencephalopathy PML 48 metastatic lesions 48 Hurthle cell 48 chlamydial infection 48 neuroendocrine cancers 48 MGd 48 pancreatic cancer 48 epithelial cancers 48 Clolar 48 PIK3CA 48 Hodgkin lymphoma HL 48 myeloma cells 48 bladder cancer 48 leukemias lymphomas 48 liver metastasis 48 precancerous colon polyps 48 metastatic RCC 48 p# mutations 48 malignant fibrous histiocytoma 48 KRAS status 48 castration resistant prostate cancer 48 paragangliomas 48 basal cell cancers 48 thymoma 48 K ras mutations 48 malignant pleural mesothelioma 48 PSADT 48 malignant melanomas 48 atherosclerotic lesions 48 H. pylori infection 48 contralateral breast cancer 48 cisplatin chemotherapy 48 penetrance 48 endometrial hyperplasia 48 acoustic neuroma benign tumor 48 asymptomatic carotid stenosis 48 nonmetastatic 48 epithelial tumors 48 pilocytic astrocytoma 48 B7 H3 48 Leukemias 48 mesotheliomas 48 anthracyclines 48 lung metastases 48 liver cancer 48 temsirolimus 47 mycophenolate mofetil 47 prostate carcinoma 47 breast endometrial 47 cerebral infarction 47 Adjuvant chemotherapy 47 Osteosarcoma 47 venous thromboembolism 47 juvenile idiopathic arthritis 47 metachronous 47 BRAF V#E 47 cancer mCRC 47 HGPIN 47 gastrointestinal stromal tumor GIST 47 carcinoid tumor 47 CIN3 47 acute lymphoid leukemia 47 severe neutropenia 47 brain tumor 47 frontotemporal dementia 47 toxicities 47 pertuzumab 47 cell lymphoma ALCL 47 taxane therapy 47 Testicular cancer 47 androgen deprivation 47 oesophageal adenocarcinoma 47 metastatic bladder 47 Malignant Melanoma 47 imatinib 47 refractory CTCL 47 metastatic renal cell 47 relapsing remitting MS 47 invasive ductal breast cancer 47 ductal breast cancer 47 CMV disease 47 stage IIIA 47 proliferative diabetic retinopathy 47 intensive statin therapy 47 lupus nephritis 47 mCRC patients 47 lymph node metastasis 47 non squamous NSCLC 47 imetelstat 47 cholangiocarcinoma 47 TNF blockers 47 IMGN# 47 invasive ductal carcinoma 47 sorafenib 47 perimenopausal women 47 GnRH agonists 47 IV melanoma 47 basal cell nevus syndrome 47 mesothelin 47 nonalcoholic steatohepatitis NASH 47 bronchogenic carcinoma 47 EGFR mutation 47 cervical lesions 47 pancreatic tumors 47 myelogenous leukemia 47 supratentorial 47 colorectal adenoma 47 low expressors 47 TGFBR1 * 6A 47 BRCA deficient 47 chemoradiotherapy 47 malignant growths 47 follicular thyroid cancer 47 clusterin 47 panobinostat 47 axillary dissection 47 axillary lymph node dissection 47 pancreatic carcinoma 47 endometrial carcinoma 47 histologies 47 metastatic gastric 47 pegylated liposomal doxorubicin 47 CIN2 + 47 superficial bladder cancer 47 candidemia 47 vismodegib 47 esophagitis 47 pCR 47 acute lymphoblastic leukemia 47 breast carcinomas 47 epithelial ovarian cancer 47 colorectal polyps 47 familial ALS 47 liver fibrosis 47 HER2 positive tumors 47 pazopanib 47 bendamustine 47 tyrosine kinase inhibitors 47 RF EMFs 47 metastatic malignant 47 MGUS 47 BRCA2 gene mutation 47 subclinical hypothyroidism 47 premalignant 47 node metastases 47 diagnosed glioblastoma multiforme 47 aneuploidy 47 childhood sunburns 47 Basal cell 47 mucinous 47 NF2 47 Relapsing remitting MS 47 neuroblastoma tumors 47 premenopausal breast cancer 47 metastatic kidney 47 Follicular Lymphoma 47 BRCA mutation 47 hepatocellular cancer 47 DIPG 47 acute myeloid leukemia AML 47 metastatic melanomas 47 ERCC1 47 pilocytic astrocytomas 47 metastatic lung cancer 47 activating mutations 47 5FU 47 EGFR mutation positive 47 Foxp3 47 leukoencephalopathy 47 depsipeptide 47 APOE e4 gene 47 IDH1 mutation 47 selenium supplementation 47 Gastric cancer 47 CLL SLL 47 Metastatic melanoma 47 lung carcinomas 47 chromosomal rearrangement 47 FOLFOX4 47 Sarcomas 47 TTF Therapy 47 HNPCC 47 intestinal metaplasia 47 androgen deprivation therapy 47 leukemia CLL 47 advanced NSCLC 47 Rectal cancer 47 GBA mutations 47 anti angiogenic therapy 47 myelodysplastic syndrome MDS 46 angiosarcoma 46 lymphoid malignancies 46 advanced neoplasia 46 bleomycin 46 Thyroid cancer 46 primitive neuroectodermal tumors 46 chronic GVHD 46 ovarian pancreatic 46 seminomas 46 EGFr 46 cranial irradiation 46 metastatic 46 papillary thyroid carcinoma 46 Torisel 46 cancerdefine 46 EoE 46 p#INK#a 46 EpCAM 46 inherited mutations 46 nonseminoma 46 lung pancreatic 46 adenoma recurrence 46 metastatic colorectal 46 hepatic metastases 46 K ras 46 ductal carcinomas 46 BRCA1 mutation carriers 46 cetuximab 46 colorectal gastric 46 epithelial ovarian 46 hormone therapy estrogen 46 histologic 46 indolent lymphomas 46 hematologic toxicity 46 grade serous ovarian 46 chronic periodontitis 46 estrogen receptor ER 46 thinner skulls 46 BRAF mutation 46 gastrointestinal stromal tumors GISTs 46 axitinib 46 Gleevec resistant 46 JAK mutations 46 cell carcinoma 46 thyroid carcinoma 46 biliary tract cancer 46 tamoxifen therapy 46 advanced medullary thyroid 46 Cutaneous T 46 anastrozole 46 systemic lupus erythematosus SLE 46 castrate resistant prostate cancer 46 hormonal therapy 46 PNET 46 pancreatic islet cell 46 gefitinib 46 myelodysplastic syndromes MDS 46 malignant glioma brain tumor 46 narcolepsy cataplexy 46 intracranial stenosis 46 gemcitabine 46 Myelodysplastic Syndrome 46 enterovirus infection 46 colorectal neoplasms 46 neurologic complications 46 acute myeloid 46 chemotherapeutic agent 46 metastatic GIST 46 lymphovascular invasion 46 testicular germ cell 46 hTERT 46 lymphoid 46 lymphocytosis 46 systemic scleroderma 46 cervical intraepithelial neoplasia 46 NFkB 46 skeletal metastases 46 neuroendocrine carcinoma 46 FluCAM 46 interferon pathway 46 mTOR inhibitors 46 atypia 46 melanoma lesions 46 anaplastic lymphoma kinase 46 Cell Lymphoma 46 myelofibrosis 46 Metastatic colorectal cancer 46 colon tumors 46 HCV infected 46 anaplastic astrocytoma 46 mRCC 46 laryngeal cancer 46 uterine ovarian 46 intestinal polyps 46 Pancreatic cancer 46 allogeneic stem cell 46 pancreatic tumor 46 bladder tumors 46 antitumor effect 46 allergic asthma 46 oligodendroglioma 46 malignant pancreatic 46 rituximab 46 CTCL 46 microRNA miR 46 cell lymphoma PTCL 46 neoadjuvant chemotherapy 46 polycythemia vera 46 nodular melanoma 46 cilengitide 46 cytotoxic chemotherapy 46 myeloproliferative disorder 46 premalignant lesions 46 primitive neuroectodermal tumor 46 carcinoids 46 hormone receptor negative 46 folate deficiency 46 prostate carcinogenesis 46 Carcinoma 46 microalbuminuria 46 myeloproliferative neoplasms 46 osteosarcoma rare 46 metastatic cancers 46 hematopoietic cancers 46 TNF α 46 imatinib Gleevec 46 metastatic malignant melanoma 46 leukemia 46 microbleeds 46 EBV infection 46 KRAS mutation 46 FTLD 46 autoantibody positive 46 ductal 46 folate intake 46 curable cancers 46 basal cell 46 multiple myeloma 46 invasive candidiasis 46 faulty BRCA genes 46 glucose metabolism 46 hypersensitivity reaction 46 Gorlin syndrome 46 venous thromboembolic events 46 HbF 46 spontaneous preterm delivery 46 advanced hepatocellular carcinoma 46 homozygous familial hypercholesterolemia 46 subtype 46 melanoma skin 46 SCCHN 46 GRP# 46 PKCi 46 colon cancer 46 FOLFOX 46 hormone receptor positive 46 scleroderma 46 cediranib 46 adenomatous 46 JAK inhibitors 46 AGTR1 46 Synovial sarcoma 46 hepatocellular carcinomas 46 erlotinib 46 HMGA2 46 cytoreduction 46 postoperative delirium 46 cell lung cancer 46 venous thrombosis 46 Smad7 46 KRAS gene 46 non hodgkin lymphoma 46 de novo AML 46 seliciclib 46 HPV infection 46 gastrointestinal stromal tumors 46 CD# + [002] 46 allogeneic SCT 46 Acute Myelogenous Leukemia AML 46 chemopreventive agent 46 HER2 positivity 46 malignant transformation 46 basal cell skin 46 temozolomide 46 aromatase 46 transthyretin 46 myeloablative 46 atherosclerotic disease 46 bortezomib 45 thyroid nodules 45 trastuzumab 45 hepatoma 45 chronic myeloid leukemia CML 45 NKX2 45 PTEN protein 45 Bcl xL 45 CDH1 45 Alessandro Riva 45 FOLFIRI 45 lobular breast cancer 45 Non Hodgkins lymphoma 45 anti angiogenic drugs 45 Doxil ® 45 colorectal polyp 45 Vectibix 45 graft dysfunction 45 mutated KRAS 45 Bladder cancer 45 thrombotic events 45 juvenile idiopathic arthritis JIA 45 cisplatin 45 cell lymphoma CTCL 45 papillary renal cell carcinoma 45 postoperative chemotherapy 45 chronic lymphocytic leukemia 45 idiopathic myelofibrosis 45 TEAEs 45 trans retinoic acid 45 de ath 45 KRAS mutations occur 45 carotid stenosis 45 ccRCC 45 Ewing sarcoma 45 nodal metastases 45 plus gemcitabine 45 DCIS 45 endocrine tumors 45 galiximab 45 HER2 positive metastatic breast 45 LQTS 45 Lymphomas 45 topotecan 45 Renal cell carcinoma 45 Epstein Barr virus EBV 45 oesophageal squamous cell carcinoma 45 lung adenocarcinomas 45 pre cancerous lesion 45 enzastaurin 45 myelodysplastic syndromes 45 FTY# 45 carcinoid cancer 45 decitabine 45 gefitinib Iressa 45 diffuse gastric 45 HER2 expression 45 pharyngeal cancer 45 leukemic cell 45 ovarian carcinomas 45 Uterine cancer 45 tuberous sclerosis TS 45 Malignant glioma 45 untreated celiac disease 45 adjuvant radiation 45 calcitriol 45 oncoproteins 45 HGPS 45 myeloproliferative disease 45 recurrent NSCLC 45 gallstone disease 45 metastatic colon cancer 45 PARP inhibition 45 estrogen receptor 45 LHRH receptor positive 45 benign breast 45 ductal carcinoma 45 HER2 receptor 45 oral squamous cell 45 lymphatic tissue 45 AAV2 45 chlorambucil 45 brain lesions 45 pancreatic prostate 45 EGFR gene 45 GIST tumors 45 angiogenesis inhibition 45 GSTP1 45 gynecologic malignancy 45 oncogenes 45 mutated KRAS gene 45 azacitidine 45 AAT deficiency 45 unresectable stage 45 KRAS mutations 45 Sadetzki 45 folate supplementation 45 chemotherapeutic regimens 45 desmoplastic 45 grade dysplasia 45 SPINK1 45 tumor metastases 45 thalidomide Thalomid 45 severe oral mucositis 45 HIV HCV coinfected 45 carotid plaque 45 hypercalcemia 45 herpes infections 45 benign tumors 45 olaparib 45 neoplastic 45 colon cancers 45 Neuroblastoma 45 myelomas 45 Medulloblastoma 45 hematopoietic malignancies 45 mutant p# 45 Chronic lymphocytic leukemia CLL 45 GNAQ 45 recurrent VTE 45 Anthony Swerdlow 45 TORISEL 45 mosaicism 45 atypical ductal hyperplasia 45 BRCA1 BRCA2 45 CHOP chemotherapy 45 childhood leukemias 45 cystatin C 45 imatinib resistant 45 CD# mAb 45 anti leukemic 45 sorafenib Nexavar 45 Metastatic 45 Alzheimer disease AD 45 JMML 45 thrombotic complications 45 Folfox 45 commercialize deforolimus 45 Gynecologic Oncology Group 45 tumor lysis syndrome 45 polyp recurrence 45 Genetic variants 45 pancreatic neuroendocrine tumors 45 serotype #A 45 neoplastic lesions 45 myeloproliferative diseases 45 clinically detectable 45 Helicobacter pylori H. pylori 45 metastatic carcinoma 45 myelofibrosis polycythemia vera 45 antitumor activity 45 gemcitabine chemotherapy 45 neoplasias 45 genetic variants 45 malignant polyps 45 FOLFIRI alone 45 Taxotere ® 45 pancreatic NET 45 lymphoblastic lymphoma 45 CDK4 45 sentinel lymph node biopsy 45 CYP#C# [001] 45 cyclin E 45 malignant neoplasms 45 KRAS mutant 45 Zyclara Cream 45 papillary RCC 45 hamartomas 45 HPV 45 cytogenetic responses 45 lymph node removal 45 precursor lesions 45 testicular tumors 45 tumor cells 45 PsA 45 venous blood clots 45 elevated CRP 45 hepatorenal syndrome 45 falciparum malaria 45 Sjögren syndrome 45 invasive lobular carcinoma 45 lymphoma subtypes 45 bilateral oophorectomy 45 thyrotoxicosis 45 HCV infection 45 mitochondrial toxicity 45 dysglycemia 45 T1c 45 gene variants 45 NOMID 45 hemorrhagic strokes 45 Myelofibrosis 45 bladder carcinoma 45 colon polyps 45 anal cancers 45 Oesophageal cancer 45 elevated triglyceride levels 45 Chronic myeloid leukemia CML 45 breast cancer 45 melanoma tumors 45 FDG PET imaging 45 NP CRNs 45 common hematologic malignancy 45 Toxicities 45 teratoma 45 LRP5 45 papillary carcinoma 45 B Cell Lymphoma 45 prophylactic cranial irradiation 45 postmenopausal hormone therapy 45 bevacizumab 45 adecatumumab 45 placebo dexamethasone 45 hyperplastic polyps 45 miRNA genes 45 recurrent metastatic 44 intracerebral hemorrhage 44 recurrent colorectal cancer 44 dysplasia 44 pleural mesothelioma 44 colorectal tumor 44 postoperative pathology 44 osteoporotic fractures 44 cutaneous squamous cell carcinoma 44 ductal adenocarcinoma 44 disease progression 44 benign growths 44 PARP inhibitors 44 ApoE4 gene 44 androgen ablation 44 Chronic Lymphocytic Leukemia CLL 44 axillary nodes 44 S. aureus infections 44 retinoblastoma 44 Ceflatonin 44 mycosis fungoides 44 leiomyomas 44 Epstein Barr virus 44 neurofibromatosis type 44 SEER database 44 efalizumab 44 stage IIIB 44 malignant prostate 44 thromboembolic disease 44 IGF1R 44 rhinosinusitis 44 HBV infection 44 breast cancer gene mutation 44 vascular dementia 44 hA# 44 VUR 44 glioblastoma multiforme tumors 44 Hodgkin lymphoma 44 Lung transplantation 44 pelvic malignancies 44 receptor tyrosine kinase inhibitor 44 metastatic breast cancer 44 mitoxantrone 44 eosinophilic asthma 44 bronchopulmonary dysplasia 44 cell malignancies 44 nilotinib 44 Mantle Cell Lymphoma 44 Faslodex 44 prolongs survival 44 lymphoproliferative disorder 44 EGFR TKI 44 NMIBC 44 xenograft tumors 44 autologous transplants 44 mutated BRAF gene 44 Hepatocellular carcinoma HCC 44 extracranial 44 proliferative retinopathy 44 Prostatitis 44 cytokine refractory 44 EGFR mutant 44 Myelodysplastic syndromes MDS 44 brain tumor glioblastoma 44 ovarian lung